Welcome to Hepatitis Delta Connect!
A dedicated program of the Hepatitis B Foundation to increase awareness about hepatitis delta - a serious virus that coinfects hepatitis B patients - and to promote screening and testing, and provide information and support for those affected.
New Blog Post! Interview with Dr. Carla Coffin!
For this month’s Hepatitis B Foundation blog post, we spoke with Dr. Carla Coffin, a hepatologist at the University of Calgary and president of the Canadian Association for the Study of the Liver. Dr. Coffin shares her insights on the prevalence, screening challenges, and treatment options for hepatitis delta in Canada, as well as the critical role of universal screening and increased awareness among healthcare providers. Dive into her expertise on addressing underdiagnosis and the importance of advocacy in shaping policies to support those affected by hepatitis delta.
Read here!
New Webinar! Patient-Reported Outcomes in Chronic Hepatitis Delta with Dr. Maria Buti
Watch the recording of a webinar with Dr Maria Buti, a leading global expert in liver disease, who presented an overview of her recent paper, "Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the Phase III MYR301 trial of bulevirtide." This study includes important data on health-related quality of life for individuals living with hepatitis delta. Check out the recording to hear Dr. Buti share insights about this important work!
Watch here!
Check Out A New Position Statement on Standardized Surveillance for Hepatitis D Virus Infections
This position statement proposes a standardized surveillance case definition for hepatitis D virus (HDV) infections, commonly known as hepatitis D. Establishing a standardized definition is important because HDV is currently a reportable disease in only 31 jurisdictions of the United States (meaning that, once an individual tests positive for hepatitis delta, this must be reported to the CDC, which would help greatly with surveillance of the disease). The case ascertainment process will rely on clinical and laboratory reports, with case classifications divided into confirmed and probable. This framework aims to improve the accuracy and comparability of HDV surveillance efforts.
Read here.
Sign up for our Patient and Provider Newsletters
We would love to hear from you! Complete the survey to sign up! Please note: This survey link is specifically for those living with hepatitis delta, or those who are caretakers of people living with hepatitis delta.
Take our brief survey & sign up to receive updates on clinical trials, info about hepatitis delta monitoring, management & care + more! Sign up today! Please note: This survey link is specifically for healthcare providers caring for people living with hepatitis delta.
We've educated 13,000 people in 111 countries!
New Clinical Practice Guidelines from the European Association for the Study of the Liver (EASL)
EASL has recently published hepatitis delta clinical guidelines with recommendations for testing and surveillance. Read the new guidelines here!
Get Connected
